SUPPRESSION OF PRINCIPAL ATHEROSCLEROTIC MECHANISMS BY PROSTACYCLINS AND OTHER EICOSANOIDS

被引：62

作者：

WILLIS, AL

SMITH, DL

VIGO, C

机构：

来源：

PROGRESS IN LIPID RESEARCH | 1986年 / 25卷

关键词：

D O I：

10.1016/0163-7827(86)90132-3

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：645 / 666

页数：22

共 179 条

[1]

ANGELO VD, 1978, THROMB HAEMATOL, V39, P535

[2] HUMAN PLATELET-DERIVED GROWTH-FACTOR (PDGF) - PURIFICATION OF PDGF-I AND PDGF-II AND SEPARATION OF THEIR REDUCED SUBUNITS [J].

ANTONIADES, HN .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (12) :7314-7317

[3] FACTORS CONTROLLING THROMBUS FORMATION ON ARTERIAL LESIONS [J].

BAUMGARTNER, HR ;

SAKARIASSEN, KS .

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 454 :162-177

[4]

BAUMGARTNER HR, 1976, ATHEROSCLEROSIS, V4, P605

[5] INFLUENCE OF HUMAN LOW-DENSITY AND HIGH-DENSITY LIPOPROTEIN CHOLESTEROL ON THE INVITRO PROSTAGLANDIN-I2 SYNTHETASE-ACTIVITY [J].

BEITZ, J ;

FORSTER, W .

BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 620 (03) :352-355

[6]

BERBERIAN PA, 1976, J LIPID RES, V17, P46

[7] INHIBITION OF CHOLESTEROL ESTERIFICATION IN RABBIT AORTA BY PROSTAGLANDIN-E2 [J].

BERBERIAN, PA ;

ZIBOH, VA ;

HSIA, SL .

ATHEROSCLEROSIS, 1977, 27 (02) :213-220

[8]

BLATTLER W, 1981, VASA-J VASCULAR DIS, V10, P261

[9]

BONNER MJ, 1972, P SOC EXP BIOL MED, V139, P1359, DOI 10.3181/00379727-139-36363

[10]

BRADLOW BA, 1986, NIH C MARINE LIPIDS

← 1 2 3 4 5 6 7 8 9 10 →